GTC Biotherapeutics (fka GTCB)

[cesrph09]

Recent trends in the sales of recombinant factor VIIa are presented in Figure 2. Since the cost of a single dose of recombinant factor VIIa ranges from $5,000 to $10,000,inappropriate use of this agent can have a considerable adverse impact on health system drug expenditures.[68,69] Until further data are available from controlled clinical trials, strict restriction and judicious use of this agent for unlabeled uses are warranted.[70] http://www.medscape.com/viewarticle/499072_3

Also decent link on relative costs of available blood factors and other products:

http://www.umd.nycpic.com/cgi-bin/bookmgr/bookmgr.exe/BOOKS/PB200509/5.2?DT=20050829161530

Hmmm, seems like a huge opportunity for LFB and GTCB. I wonder what there cost will be?